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to Pre-Clinical Diastolic Dysfunction?:
Think About Exercise Training!We thank Dr. Pressler and colleagues for their interest
in our paper (1). The progression of pre-clinical dia-
stolic dysfunction (PDD) to symptomatic heart failure
with preserved ejection fraction (HFpEF) is depen-
dent on a variety of comorbid conditions, including
pulmonary, renal, and hematologic dysfunction (1).
Because exercise testing may be signiﬁcant in the
diagnosis and prognosis of HFpEF, it follows that
cardiopulmonary rehabilitation may be an important
nonpharmacological intervention.
Edelmann et al. (2) have demonstrated in their
pilot multicenter trial of HFpEF subjects that exercise
improves diastolic function parameters as well as the
outcomes of exercise capacity and quality of life. In
their letter, they emphasize the importance of exer-
cise training for those with diastolic dysfunction.
Cardiac rehabilitation has been shown to have
beneﬁcial effects on symptomatic heart failure as well
as on coronary artery disease. However, its beneﬁt in
patients with stage B or pre-clinical heart failure
remains undeﬁned. Beneﬁts of exercise include, not
only enhanced cardiac function, but also increased
minute ventilation and oxygen utilization, and
improved endothelial, neuroendocrine activity, and
muscle metabolism (3). Because the underlying path-
ophysiology of PDD progression is dependent on
multiple organ systems, cardiopulmonary exercisetherefore may indeed provide, not only diastolic
function beneﬁts, but also pulmonary, hematologic,
and renal beneﬁts as well.
Dr. Pressler and colleagues highlight that an
important aspect of PDD and HFpEF management is
nonpharmacological intervention. In addition to ex-
ercise, other basic nonpharmacological interventions,
such as education, diet, ﬂuid restriction, alcohol and
smoking cessation, and appropriate vaccinations, may
also be important in the cessation of the downward
heart failure spiral (4).
Further studies are needed to better characterize
which of the underlying physiological beneﬁts of
cardiopulmonary exercise directly contribute to the
reduction of heart failure progression, which may
lead to directed exercise activities speciﬁcally to
better target cardiac, pulmonary, or hematologic
dysfunction.Siu-Hin Wan, MD
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